ProQR shares spike on positive PoC study for lead CF drug
Shares of the Dutch biotech ProQR Therapeutics $PRQR shot up this morning after it released upbeat results from an early proof-of-concept study for its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
